Search For "covaxin"
Bharat Biotech to rectify issues raised by WHO on Covaxin soon: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], April 4 (ANI): Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues raised by the World Health Organization regarding its COVID-19 vaccine-- Covaxin-- in a few days and added that the company has informed about this development to the Drugs Con
Read More
WHO suspension for Covaxin supply only for UN agencies: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], April 4 (ANI): The World Health Organization's (WHO) suspension of supplies of Covaxin of the Bharat Biotech supply is not related to safety or efficacy issues but only to supply for United Nations agencies, sources said.
Read More
No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO susp
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana)[India], April 3 (ANI): Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the COVID-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility.
Read More
Bharat Biotech temporarily slows down COVAXIN production for facility opti
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 1 (ANI): Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.
Read More
Covaxin-maker Bharat Biotech MD D Krishna Ella, Joint MD Suchitra Ella con
Updated : 3 years, 12 months ago IST
New Delhi [India], March 28 (ANI): Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath Kovind on Monday.
Read More
COVID-19: FDA gives clearance to Covaxin for clinical trials in adults in
Updated : 4 years ago IST
New Delhi [India], March 7 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
Read More
Bill Gates lauds India's commitment to global health
Updated : 4 years, 1 month ago IST
Washington [US], February 24 (ANI): Microsoft co-founder Bill Gates, at a virtual event of the India-US Health Partnership roundtable on "Vaccine for All", on Tuesday, said that India's 3 vaccines -- Covaxin, Corbavex and Covishield -- were the products of partnerships that bridged sectors a
Read More
Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotec
Updated : 4 years, 1 month ago IST
Hyderabad (Telangana) [India], February 19 (ANI): Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.
Read More
COVAXIN approved for emergency use in 13 countries: MoS for Health Bharati
Updated : 4 years, 1 month ago IST
New Delhi [India], February 8 (ANI): Covaxin has been granted approval for emergency use in 13 countries as of January 31, 2022, according to the WHO, said Minister of State (MoS) for Health Bharati Pravin Pawar in Lok Sabha on February 4.
Read More
Covaxin, Covishield given normal new drug permission in adult population w
Updated : 4 years, 1 month ago IST
New Delhi [India], January 27 (ANI): Union Health Minister Dr Mansukh Mandaviya on Thursday said that the Central Drugs Standard Control Organisation (CDSCO) has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permissio
Read More
DCGI grants conditional market approval for Covaxin, Covishield
Updated : 4 years, 1 month ago IST
New Delhi [India], January 27 (ANI): The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.
Read More
Regular market approval to Covishield, Covaxin expected soon after final p
Updated : 4 years, 1 month ago IST
New Delhi [India], January 26 (ANI): The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is expected soon, but only after price fixation which is still underway, official sources told ANI on Wednesday.
Read More